| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Crispr Therapeutics AG (CRSP) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 50 sells. CRSP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 255.5K | $13.92M | - | |
| Dir | 22.0K | $1.20M | - | |
| CFO | 19.5K | $1.06M | - | |
| Other | 19.4K | $1.05M | -3,786 | |
| Other | 17.0K | $926.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2021 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 30,000 | $128.78 | $3,863,468.55 | -2.5% | -27.4% | -39.0% | |
| Jul 19, 2021 | Bolzon Bradley J Phd75 | Director | Sell | 10,000 | $126.43 | $1,264,347.53 | -1.6% | -23.5% | -33.4% | |
| Jun 30, 2021 | Novak Rodger75 | President | Sell | 25,000 | $165.00 | $4,125,000.00 | -4.2% | -30.7% | -62.5% | |
| Jun 29, 2021 | Bolzon Bradley J Phd75 | Director | Sell | 47,536 | $149.49 | $7,106,341.02 | -20.0% | -22.1% | -58.1% | |
| Jun 28, 2021 | Bolzon Bradley J Phd75 | Director | Sell | 30,375 | $152.48 | $4,631,582.53 | -2.5% | -22.7% | -58.3% | |
| Jun 28, 2021 | Novak Rodger75 | President | Sell | 25,000 | $156.55 | $3,913,750.00 | -4.0% | -22.7% | -58.3% | |
| Jun 21, 2021 | Novak Rodger75 | President | Sell | 25,000 | $128.62 | $3,215,458.23 | -0.7% | -10.1% | -50.1% | |
| Jun 15, 2021 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 30,000 | $126.43 | $3,792,804.19 | -4.9% | -4.5% | -49.3% | |
| Jun 11, 2021 | Bolzon Bradley J Phd75 | Director | Sell | 10,000 | $126.61 | $1,266,118.41 | -8.2% | -4.4% | -49.8% | |
| Mar 23, 2021 | Klein Lawrence Otto | Cbo &COO | Sale+OE | 100,000 | $128.05 | $12,805,240.00 | -87.6% | +2.5% | -49.7% |